EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders.
The excitatory amino acid transporter 2 (EAAT2) is responsible for the majority of glutamate uptake in the brain and its dysregulation has been associated with multiple psychiatric and neurological disorders. However, investigation of this molecule has been complicated by its complex pattern of alternative splicing, including three coding isoforms and multiple 5'- and 3'-UTRs that may have a regulatory function. It is likely that these sequences permit modulation of EAAT2 expression with spatial, temporal and or activity-dependent specificity; however, few studies have attempted to delineate the function of these sequences. Additionally, there are problems with the use of antibodies to study protein localization, possibly due to posttranslational modification of critical amino acid residues. This review describes what is currently known about the regulation of EAAT2 mRNA and protein isoforms and concludes with a summary of studies showing dysregulation of EAAT2 in psychiatric and neurological disorders. EAAT2 has been either primarily or secondarily implicated in a multitude of neuropsychiatric diseases in addition to the normal physiology of learning and memory. Thus, this molecule represents an intriguing therapeutic target once we improve our understanding of how it is regulated under normal conditions.
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA.
T L
TL
Lauriat
L A
LA
McInnes
D027342:Excitatory Amino Acid Transporter 2 / Q000235:genetics*; D006801:Humans; D001523:Mental Disorders / Q000235:genetics*; D009422:Nervous System Diseases / Q000235:genetics*; D012326:RNA Splicing / Q000235:genetics*
D027342:Excitatory Amino Acid Transporter 2